Increased DNCB reactivity after administration of the immunostimulatory compound azimexone to cancer patients during chemoradiotherapy | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

HERO ID

8242819

Reference Type

Journal Article

Title

Increased DNCB reactivity after administration of the immunostimulatory compound azimexone to cancer patients during chemoradiotherapy

Author(s)

Krischke, W; Niederle, N; Boerner, D

Year

1982

Is Peer Reviewed?

Yes

Journal

International Journal of Immunopharmacology
ISSN: 0192-0561

Volume

Issue

Page Numbers

339

Language

English

DOI